Advertisement

Topics

Keel Pharmaceuticals, Inc. Company Profile

11:47 EDT 18th June 2018 | BioPortfolio

Keel Pharmaceuticals, Inc. is a private biopharmaceutical company that is developing new therapies to treat type 1 diabetes and other autoimmune diseases. Keels technology is based on the identification of specific protein processing and signalling defects present in the autoreactive white blood cells (lymphocytes) that cause autoimmune diseases. The identification of these defects has yielded a proprietary approach to the treatment of autoimmunity based on selective destruction of auto reactive lymphocytes and re-establishment of immune tolerance. Current therapies for autoimmune diseases and the majority of therapies under development target either the biochemical by-products of autoimmune diseases or classes of lymphocytes generally (i.e., whether they are autoreactive or not). By treating the causes of autoimmunity directly, Keels therapies have the potential to provide patients with long-lasting relief from disease and, perhaps, permanent reversal.

Location

215 First Street, Suite 104
Cambridge
Massachusetts
02142
United States of America

Contact

Phone: 617/225-0834
Fax: 617/225-0835
Email: research@keelpharmaceuticals.com.


News Articles [475 Associated News Articles listed on BioPortfolio]

Global and Chinese Keel Pliers Industry, 2017 Market Research Report [Report Updated: 18122017] Prices from USD $3000

The 'Global and Chinese Keel Pliers Industry, 20122022 Market Research Report' is a professional and indepth study on the current state of the global Keel Pliers industry with a focus on the Chinese m...

Resolving to have a happier, healthier 2018? Reshape your body attitudes

(Florida State University) Psychology Professor Pamela Keel describes research that offers an entirely different perspective on New Year's resolutions.

Team Freedom Lays Keel on Nation's 21st Littoral Combat Ship

"It is a tremendous honor to serve as the sponsor of the future USS Minneapolis- Saint Paul," Greene said. "I look forward to supporting Read more...

Lindblad Expeditions Holdings, Inc. Celebrates Keel Laying Of First Polar New Build

"We are thrilled to announce the name of our new polar ship: National Geographic Endurance,due for delivery in the first quarter of 2020," Read more...

Critical Contrast: Ironwood Pharmaceuticals

Ironwood Pharmaceuticals and Infinity Pharmaceuticals are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, d...

Critical Analysis: Sagent Pharmaceuticals

Sagent Pharmaceuticals and Lannett are both pharmaceuticals - nec companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analy...

GW Pharmaceuticals ADR: Kommt es jetzt zum Ausbruch? Trading-Chance!

Es gibt ein weiteres Unternehmen GW Pharmaceuticals, das vorwiegend Cannabis herstellt und somit als "Pflanzenzüchter" zu werten ist. GW Pharmaceuticals ADR ist ein Biotech-Unternehmen, das sich zw.....

Telix Pharmaceuticals Limited: Telix Pharmaceuticals, INSERM and ARRONAX Enter into Translational Research Partnership

MELBOURNE, Australia and NANTES, France, April 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) ("Telix", the "Company"), a clinical-stage biopharmaceutical company focused on ...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [140 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Radiographic examination of keel bone damage in living laying hens of different strains kept in two housing systems.

A high prevalence of deviations and fractures of the keel bone is a widespread welfare problem in laying hens. The aim of this study was to experimentally investigate this multifactorial problem throu...

Limestone particle size fed to pullets influences subsequent bone integrity of hens.

This study was conducted to evaluate limestone particle size (LPS) in 2 strains of laying hens housed in conventional cages or aviaries on bone integrity. Lohmann Brown and Bovan White pullet chicks w...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Clinical Trials [216 Associated Clinical Trials listed on BioPortfolio]

Evaluation of Triathlon - A New Total Knee Prosthesis System - RSA Triathlon Standard vs. Short Keel

The objective is to investigate the Clinical, Radiographic, Roentgen Stereophotogrammetric behaviour and patient outcome when using the Triathlon total knee prosthesis in a prospective ran...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Companies [1322 Associated Companies listed on BioPortfolio]

Keel Pharmaceuticals, Inc.

Keel Pharmaceuticals, Inc. is a private biopharmaceutical company that is developing new therapies to treat type 1 diabetes and other autoimmune diseases. Keels technology is based on the identificat...

Chemnitzer Wirtschaftsfoerderungs

The Chemnitz Business promotion and Development Association, known as CWE for short, is constantly at your disposal as a competent partner in all matters regarding relocation to Chemnitz, founding a b...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

More Information about "Keel Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Keel Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Keel Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Keel Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Keel Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Keel Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...


Corporate Database Quicklinks



Searches Linking to this Company Record